| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 747292 | Null | 0.000141616984257997 | 0.77314277 |
| NSC 755417 | Null | 0.000141616984257997 | 0.60967472 |
| NSC 128571 | Ethanesulfonic acid, compd. with 2-chloro-5-[4-[2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) (8CI) | 0.000150163566228975 | 0.68107873 |
| NSC 335766 | Quinazoline, 4-ethyl-6-methoxy-7-(oxiranylmethoxy)- | 0.000150163566228975 | 0.55797606 |
| NSC 633713 | N.ALPHA.-(4-AMINO-4-DEOXYLPTEROYL)-N.DELTA.-HEMIPHTHALOYL-L-ORNITHINE | 0.000150163566228977 | 0.72696897 |
| NSC 128687 | 6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidine-2-methanol, 2,3,3a,9a-tetrahydro-6-imino-3-(phosphonooxy)-, (2R-(2.alpha.,3.beta.,3a.beta.,9a.beta.))- (9CI) | 0.000174252554411806 | 0.51985784 |
| NSC 301477 | 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-4-O-methyl-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S-cis)- | 0.000174252554411806 | 0.54406567 |
| NSC 692581 | Null | 0.000174252554411808 | 0.44611686 |
| NSC 696921 | Null | 0.000174252554411808 | 0.19902236 |
| NSC 757113 | METHOTREXATE(+/-) | 0.000174252554411808 | 0.79525318 |